Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8691881 | World Neurosurgery | 2018 | 12 Pages |
Abstract
New diagnostic modalities, the introduction of broad-spectrum antibiotics, and recent advances in neurosurgical procedures have led to a decrease in the rate of treatment failure in cranial osteomyelitis. Early recognition of initial nonspecific symptoms is key to diagnosing and managing this treatable but life-threatening condition. Early identification of the causative pathogen, appropriate broad-spectrum antibiotic therapy over a period of 8-20 weeks, and aggressive surgical debridement are essential for managing cranial osteomyelitis. On the other hand, inadequate treatment is responsible for refractory cases and poses a great diagnostic challenge. A new classification dividing cranial osteomyelitis into sinorhino-otogenic versus nonsinorhino-otogenic groups could prove valuable for clinical communication and treatment.
Keywords
Related Topics
Life Sciences
Neuroscience
Neurology
Authors
Martin M. Mortazavi, Muhammad Adnan Khan, Syed A. Quadri, Sajid S. Suriya, Kian M. Fahimdanesh, Salman A. Fard, Tania Hassanzadeh, M. Asif Taqi, Hannah Grossman, R. Shane Tubbs,